NCT01408225View on ClinicalTrials.gov

Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource

RecruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

March 17, 2011

Primary Completion Date

March 31, 2050

Study Completion Date

March 31, 2050

Conditions
Plasma Cell DyscrasiasMonoclonal Gammopathy of Undetermined SignificanceAL AmyloidosisMultiple Myeloma
Interventions
PROCEDURE

tissue banking

tissue procurement for this protocol will occur at the time of initial diagnosis, during routine follow-up, or at the time of relapse.

Trial Locations (1)

43210

RECRUITING

Ohio State University Medical Center, Columbus

All Listed Sponsors
lead

Ohio State University Comprehensive Cancer Center

OTHER

NCT01408225 - Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource | Biotech Hunter | Biotech Hunter